NCT01567449

Brief Summary

The purpose of this study is to examine the risk factors for aneurysm rebleeding.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

March 25, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 30, 2012

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

March 30, 2012

Status Verified

March 1, 2012

Enrollment Period

6 months

First QC Date

March 25, 2012

Last Update Submit

March 28, 2012

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Outcome Measures

Primary Outcomes (1)

  • Aneurysm rebleeding

    up to 7 months

Study Arms (2)

the case group

The case group referred to SAH patients with aneurysm rebleeding

the control group

the control group referred to SAH patients not with aneurysm rebleeding

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 66 SAH patients were enrolled in this study

You may qualify if:

  • Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included

You may not qualify if:

  • Rebleeding patients with certain inducing factors such as:
  • severe emotional episode,
  • severe coughing,
  • constipation,
  • excessive activities, or
  • with coagulation disorder,or
  • with other intracranial vascular malformations,such as:
  • moyamoya disease,
  • arteriovenous malformation were excluded.
  • Also patients who rebled while angiography were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital,Fujian Medical University

Fuzhou, Fujian, 350005, China

RECRUITING

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Dezhi kang, professor

    First Affiliated Hospital of Fujian Medical University

    STUDY DIRECTOR

Central Study Contacts

qingsong lin, master

CONTACT

13489991226lqs1210305061@163.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Junior Doctor of Neurosurgery,Principal Investigator,Clinical Doctor

Study Record Dates

First Submitted

March 25, 2012

First Posted

March 30, 2012

Study Start

September 1, 2011

Primary Completion

March 1, 2012

Study Completion

April 1, 2012

Last Updated

March 30, 2012

Record last verified: 2012-03

Locations

CN(1)